DK0600372T3 - Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer. - Google Patents

Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.

Info

Publication number
DK0600372T3
DK0600372T3 DK93118993.0T DK93118993T DK0600372T3 DK 0600372 T3 DK0600372 T3 DK 0600372T3 DK 93118993 T DK93118993 T DK 93118993T DK 0600372 T3 DK0600372 T3 DK 0600372T3
Authority
DK
Denmark
Prior art keywords
proinsulin
preparation
properly connected
cystine bridges
connected cystine
Prior art date
Application number
DK93118993.0T
Other languages
Danish (da)
English (en)
Inventor
Rainer Dr Obermeier
Martin Dr Gerl
J Ludwig
Walter Sabel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0600372T3 publication Critical patent/DK0600372T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93118993.0T 1992-12-02 1993-11-25 Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer. DK0600372T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4240420 1992-12-02

Publications (1)

Publication Number Publication Date
DK0600372T3 true DK0600372T3 (da) 1997-08-11

Family

ID=6474135

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93118993.0T DK0600372T3 (da) 1992-12-02 1993-11-25 Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.

Country Status (13)

Country Link
US (1) US5473049A (ja)
EP (1) EP0600372B1 (ja)
JP (1) JP2798351B2 (ja)
AT (1) ATE148710T1 (ja)
AU (1) AU662083B2 (ja)
CA (1) CA2110442C (ja)
DE (1) DE59305396D1 (ja)
DK (1) DK0600372T3 (ja)
ES (1) ES2097426T3 (ja)
FI (1) FI108727B (ja)
HK (1) HK1006170A1 (ja)
NO (1) NO308216B1 (ja)
SG (1) SG46612A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
ATE364701T1 (de) * 1995-02-20 2007-07-15 Inst Medical W & E Hall Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
US6924120B1 (en) 1998-03-31 2005-08-02 Tonghua Gantech Biotechnology, Ltd. Chaperone protein containing an intramolecular chaperone-like sequence and its application to insulin production
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
WO2000040612A1 (en) * 1999-01-06 2000-07-13 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
DE60016560T2 (de) 1999-01-06 2005-12-15 Genentech, Inc., South San Francisco Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i)
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
AU2151401A (en) 1999-12-22 2001-07-03 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
CN101605889A (zh) * 2008-02-12 2009-12-16 伊藤火腿株式会社 含有高表达分泌胰岛素前体的融合蛋白、编码该融合蛋白的dna和胰岛素的制备方法
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
AR080669A1 (es) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (pt) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
WO2014099577A1 (en) 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
PL3229828T3 (pl) 2014-12-12 2023-07-31 Sanofi-Aventis Deutschland Gmbh Formulacja o ustalonym stosunku insuliny glargine/liksysenatydu
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU76881A (en) 1980-03-27 1984-04-30 Lilly Co Eli Process for obtaining insulin precursors
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
DE4012818A1 (de) 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3726655A1 (de) 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
DE58906966D1 (de) 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
GB8819826D0 (en) * 1988-08-20 1988-09-21 Kabivitrum Ab Glycosylated igf-1
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
IL95495A (en) 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use

Also Published As

Publication number Publication date
US5473049A (en) 1995-12-05
CA2110442A1 (en) 1994-06-03
NO934357D0 (no) 1993-11-30
ES2097426T3 (es) 1997-04-01
EP0600372A1 (de) 1994-06-08
AU5203993A (en) 1994-06-16
JP2798351B2 (ja) 1998-09-17
AU662083B2 (en) 1995-08-17
FI108727B (fi) 2002-03-15
EP0600372B1 (de) 1997-02-05
CA2110442C (en) 2004-05-04
FI935358A (fi) 1994-06-03
FI935358A0 (fi) 1993-11-30
DE59305396D1 (de) 1997-03-20
JPH06228191A (ja) 1994-08-16
HK1006170A1 (en) 1999-02-12
ATE148710T1 (de) 1997-02-15
SG46612A1 (en) 1998-02-20
NO934357L (no) 1994-06-03
NO308216B1 (no) 2000-08-14

Similar Documents

Publication Publication Date Title
DK0600372T3 (da) Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
CA2142780A1 (en) Process for obtaining insulin having correctly linked cystine bridges
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
DK659689D0 (da) Fremgangsmaade til fremstilling af farvede, stabiliserede blegemiddelaktivatorekstrudater og vaskemiddel omfattende samme
FI934934A (fi) Stympade former av hepatocytvaextfaktorreceptor
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
DK0585939T3 (da) TNF-ligander
ATE199560T1 (de) Festphasensynthese von oligoribonucleotiden
DK96390D0 (da) Copoly-(arylensulfider) og fremgangsmaade til deres fremstilling
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
ATE90689T1 (de) Fragment von hepatitis-b-innenkoerperantigen.
BR8600260A (pt) Processo para a preparacao de triacetoxissilanas a partir de tris(amino)silanas
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
DK0612745T3 (da) Fremgangsmåde til fremstilling af 1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepin og salte deraf
ES2086947T3 (es) Metodo para encolar productos basados en madera.
DK0704438T3 (da) Fremgangsmåde til fremstilling af 2-cyaniminothiazolidin
FI921356A (fi) Somatostatinreceptor
DK530889A (da) Fremgangsmaade til nedsaettelse af aggregatindholdet af vaeksthormonlignende materialer
DK0647623T3 (da) Mellemprodukter til fremstilling af A-vitamin og carotenoider samt fremstilling og anvendelse af disse mellemprodukter
DK0599036T3 (da) Fremgangsmåde til fremstilling af 2-aryl-5-trifluormethyl-pyrrolforbindelser
DK604783A (da) Fremgangsmaade til fremstilling af et funktionelt hydrolysat ud fra mikrobielle proteinisolater
IT1230519B (it) Miscela di caucciu' reticolabile, in particolare vulcanizzabile mediante zolfo.
EP0141560A3 (en) Chemical process
DE3573111D1 (en) Process for separating methyl isocyanate